ONC
Beone Medicines·NASDAQ
--
--(--)
--
--(--)
ONC fundamentals
Beone Medicines (ONC) released its earnings on Feb 26, 2026: revenue was 1.50B (YoY +32.84%), beat estimates; EPS was 0.06 (YoY +104.20%), missed estimates.
Revenue / YoY
1.50B
+32.84%
EPS / YoY
0.06
+104.20%
Report date
Feb 26, 2026
Earnings Call
8:00 AM on Feb 26, 2026
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
ONC has released its 2025 Q4 earnings report, with revenue of 1.50B, reflecting a YoY change of 32.84%, and net profit of 66.50M, showing a YoY change of 143.79%. The Sankey diagram below clearly presents ONC's revenue sources and cost distribution.
Key Indicators
Beone Medicines (ONC) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Beone Medicines (ONC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Beone Medicines (ONC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Beone Medicines (ONC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Beone Medicines (ONC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Beone Medicines (ONC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Beone Medicines's latest dividend and current dividend yield?What is the market's earnings forecast for Beone Medicines next quarter?What factors drove the changes in Beone Medicines's revenue and profit?What is Beone Medicines's gross profit margin?What guidance did Beone Medicines's management provide for the next earnings period?What does Beone Medicines do and what are its main business segments?Did Beone Medicines beat or miss consensus estimates last quarter?What were the key takeaways from Beone Medicines's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
